Ratings by Goldman Sachs (Robert Jones)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/2/2023 | Align Technology | ALGN | Upgrade | Neutral (Sell) |
282.53 (305.29) |
8.06% | Details | |
10/28/2022 | Align Technology | ALGN | Maintain | Sell (N/A) |
|
Details | ||
7/28/2022 | Align Technology | ALGN | Downgrade | Sell (Buy) |
262.61 (305.29) |
16.25% | Details | |
5/10/2021 | agilon health Inc | AGL | New Coverage | Buy (N/A) |
32.07 (27.22) |
-15.12% | Details | |
4/22/2021 | Anthem | ANTM | Maintain | Neutral (N/A) |
|
Details | ||
4/20/2021 | Alignment Healthcare Inc | ALHC | New Coverage | Neutral (N/A) |
26.06 (6.19) |
-76.25% | Details | |
3/29/2021 | Oscar Health Inc | OSCR | New Coverage | Buy (N/A) |
27.17 (5.61) |
-79.35% | Details | |
3/25/2021 | Rite-Aid | RAD | Maintain | Sell (Sell) |
|
Details | ||
3/11/2021 | Accolade Inc. | ACCD | New Coverage | Buy (N/A) |
43.59 (13.06) |
-70.04% | Details | |
3/8/2021 | Signify Health Inc | SGFY | New Coverage | Neutral (N/A) |
27.74 (30.49) |
9.91% | Details | |
3/4/2021 | Anthem | ANTM | Maintain | Neutral (Neutral) |
|
Details | ||
3/1/2021 | Health Catalyst Inc. | HCAT | Maintain | Buy (N/A) |
|
Details | ||
3/1/2021 | Evolent Health | EVH | Maintain | Neutral (N/A) |
|
Details | ||
3/1/2021 | Allscripts | MDRX | Maintain | Sell (N/A) |
|
Details | ||
2/18/2021 | Charles River Labs | CRL | Maintain | Buy (N/A) |
|
Details | ||
2/1/2021 | Align Technology | ALGN | Maintain | Buy (N/A) |
|
Details | ||
1/21/2021 | Molina Healthcare | MOH | New Coverage | Neutral (N/A) |
222.63 (265.79) |
19.39% | Details | |
1/21/2021 | Coach | COH | New Coverage | Neutral (N/A) |
39.90 (39.90) |
0% | Details | |
1/8/2021 | Walgreens Boosts Alliance | WBA | Maintain | Sell (N/A) |
|
Details | ||
11/11/2020 | Oak Street Health | OSH | Maintain | Buy (N/A) |
|
Details | ||
10/23/2020 | Align Technology | ALGN | Maintain | Buy (N/A) |
|
Details | ||
10/1/2020 | Syneos | SYNH | Upgrade | Buy (Neutral) |
52.97 (34.33) |
-35.19% | Details | |
8/31/2020 | Oak Street Health | OSH | New Coverage | Buy (N/A) |
44.56 (36.25) |
-18.65% | Details | |
8/6/2020 | PPD Inc. | PPD | Maintain | Buy (N/A) |
|
Details | ||
8/6/2020 | Charles River Labs | CRL | Maintain | Buy (N/A) |
|
Details | ||
8/5/2020 | Evolent Health | EVH | Maintain | Neutral (N/A) |
|
Details | ||
7/27/2020 | Accolade Inc. | ACCD | New Coverage | Buy (N/A) |
32.54 (13.06) |
-59.86% | Details | |
7/23/2020 | Align Technology | ALGN | Maintain | Buy (N/A) |
|
Details | ||
7/21/2020 | Allscripts | MDRX | Downgrade | Sell (Neutral) |
7.21 (12.99) |
80.17% | Details | |
7/2/2020 | Livongo Health Inc. | LVGO | Downgrade | Neutral (Buy) |
74.41 (139.77) |
87.84% | Details | |
6/8/2020 | Evolent Health | EVH | Maintain | Neutral (N/A) |
|
Details | ||
6/5/2020 | Evolent Health | EVH | Downgrade | Neutral (Buy) |
6.30 (30.50) |
384.13% | Details | |
6/5/2020 | Change Healthcare Inc. | CHNG | Maintain | Buy (N/A) |
|
Details | ||
6/5/2020 | Anthem | ANTM | New Coverage | Neutral (N/A) |
289.27 (482.58) |
66.83% | Details | |
6/5/2020 | UnitedHealth Group | UNH | New Coverage | Buy (N/A) |
305.35 (472.58) |
54.77% | Details | |
6/5/2020 | Humana | HUM | New Coverage | Buy (N/A) |
393.73 (483.41) |
22.78% | Details | |
6/4/2020 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
5/13/2020 | Health Catalyst Inc. | HCAT | Maintain | Buy (N/A) |
|
Details | ||
5/1/2020 | Pinduoduo Inc. | PDD | Maintain | Buy (N/A) |
|
Details | ||
3/30/2020 | PRA Health Sciences | PRAH | Maintain | Neutral (N/A) |
|
Details | ||
3/30/2020 | Charles River Labs | CRL | Maintain | Buy (N/A) |
|
Details | ||
3/30/2020 | PPD Inc. | PPD | Maintain | Buy (N/A) |
|
Details | ||
3/30/2020 | Iconix Brand | ICON | Maintain | Buy (N/A) |
|
Details | ||
3/30/2020 | IQVIA Holdings | IQV | Maintain | Conviction Buy (N/A) |
|
Details | ||
3/30/2020 | Syneos | SYNH | Downgrade | Neutral (Buy) |
43.92 (34.33) |
-21.84% | Details | |
3/18/2020 | McKesson | MCK | Upgrade | Buy (Neutral) |
121.28 (354.48) |
192.28% | Details | |
3/2/2020 | PPD Inc. | PPD | New Coverage | Buy (N/A) |
35.18 (47.30) |
34.45% | Details | |
2/20/2020 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
2/12/2020 | Charles River Labs | CRL | Maintain | Buy (N/A) |
|
Details | ||
1/10/2020 | Charles River Labs | CRL | Upgrade | Buy (Neutral) |
157.05 (191.89) |
22.18% | Details | |
1/10/2020 | PRA Health Sciences | PRAH | Downgrade | Neutral (Buy) |
107.71 (165.21) |
53.38% | Details | |
12/4/2019 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
10/24/2019 | Livongo Health Inc. | LVGO | Maintain | Buy (N/A) |
|
Details | ||
10/7/2019 | HealthEquity, Inc | HQY | New Coverage | Neutral (N/A) |
54.53 (57.47) |
5.39% | Details | |
9/19/2019 | PRA Health Sciences | PRAH | New Coverage | Buy (N/A) |
105.15 (107.71) |
2.43% | Details | |
8/19/2019 | Livongo Health Inc. | LVGO | New Coverage | Buy (N/A) |
34.03 (74.41) |
118.66% | Details | |
8/19/2019 | Health Catalyst Inc. | HCAT | New Coverage | Buy (N/A) |
41.51 (11.26) |
-72.87% | Details | |
7/22/2019 | Change Healthcare Inc. | CHNG | New Coverage | Buy (N/A) |
13.62 (27.49) |
101.84% | Details | |
3/13/2019 | Rite-Aid | RAD | Maintain | Sell (Sell) |
|
Details | ||
1/16/2019 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
1/16/2019 | Cardinal Health | CAH | Maintain | Neutral (N/A) |
|
Details | ||
1/16/2019 | McKesson | MCK | Maintain | Neutral (N/A) |
|
Details | ||
1/16/2019 | AmerisourceBergen | ABC | Maintain | Buy (N/A) |
|
Details | ||
1/11/2019 | IQVIA Holdings | IQV | Upgrade | Conviction Buy (Buy) |
122.16 (189.87) |
55.43% | Details | |
12/20/2018 | Rite-Aid | RAD | Maintain | Sell (N/A) |
|
Details | ||
12/14/2018 | Walgreens Boosts Alliance | WBA | Downgrade | Sell (Neutral) |
82.44 (33.82) |
-58.98% | Details | |
11/29/2018 | CVS Health | CVS | New Coverage | Neutral (N/A) |
79.50 (73.12) |
-8.03% | Details | |
10/19/2018 | Align Technology | ALGN | Maintain | Buy (N/A) |
|
Details | ||
9/28/2018 | Rite-Aid | RAD | Maintain | Sell (Sell) |
|
Details | ||
9/6/2018 | Rite-Aid | RAD | New Coverage | Sell (N/A) |
1.37 (2.11) |
54.01% | Details |